Sterile and Antiviral Packaging Market Surge: Propelling Forward at a 4.6% CAGR by 2034

The global sterile and antiviral packaging market, which generated USD 24.6 billion in revenue in 2023, is expected to grow by 4.6% year-on-year in 2024, reaching an estimated value of USD 25.7 billion. Over the forecast period from 2024 to 2034, the market is projected to expand at a compound annual growth rate (CAGR) of 3.8%, ultimately reaching a value of USD 37.5 billion by 2034.

As one of the fastest-growing sectors globally, the healthcare industry significantly contributes to a nation’s economic development. Anticipated growth in the healthcare industry, fueled by an increasing prevalence of chronic illnesses and advancements in healthcare infrastructure worldwide, is expected to drive heightened demand for medical products like trays, clamshells, bags, and pouches in the foreseeable future.

Request Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-11298

Market Drivers:

1. Increasing Concerns about Healthcare-Associated Infections (HAIs): The rising awareness of healthcare-associated infections and the need for preventing the spread of diseases contribute to the demand for sterile packaging in the medical and pharmaceutical sectors.
2. Growth in Pharmaceutical and Healthcare Industries: The expanding pharmaceutical and healthcare industries worldwide drive the demand for sterile and antiviral packaging solutions to ensure the safety and efficacy of medical products.
3. Stringent Regulations and Quality Standards: The implementation of stringent regulations and quality standards by regulatory bodies encourages the adoption of advanced packaging technologies to meet compliance requirements and ensure product safety.
4. Growing Emphasis on Infection Control: The increasing emphasis on infection control measures, especially in healthcare settings, pushes the demand for packaging solutions that help prevent contamination and the spread of viruses and bacteria.
5. Technological Advancements in Packaging Materials: Continuous innovations in packaging materials, such as barrier coatings and antiviral coatings, contribute to the development of more effective and reliable sterile and antiviral packaging solutions.

Market Restraints:

1. High Cost of Sterile Packaging Materials: The cost associated with manufacturing and using sterile packaging materials can be relatively high, impacting the overall cost of products. This can be a constraint, especially for smaller businesses.
2. Environmental Concerns: Some sterile packaging materials may raise environmental concerns due to their non-biodegradable nature. This can lead to increased scrutiny and demand for more sustainable packaging solutions.
3. Complexity in Recycling: Certain sterile packaging materials may pose challenges in terms of recycling, leading to environmental issues and a push for more eco-friendly packaging alternatives.
4. Limited Shelf Life of Antiviral Coatings: Antiviral coatings may have a limited shelf life, and their effectiveness can decrease over time, which may be a challenge in maintaining long-term protection.
5. Global Supply Chain Disruptions: The COVID-19 pandemic has highlighted vulnerabilities in global supply chains. Disruptions in the supply chain can affect the availability and cost of packaging materials, impacting the sterile and antiviral packaging market.

Key Takeaways:

• The Global Sterile and Antiviral Packaging Market is projected to reach US$ 37.9 billion by 2030, with a CAGR of 5.3% from 2022 to 2030.
• High demand for life-saving drugs and vaccines drives the astonishing growth of sterile and antiviral packaging sales.
• Vials & ampoules, along with blister & clamshell packaging types, are the most widely used in the market, accounting for over one-third of the market share in 2022.
• Plastics and metals combined make up around four-fifths of the total sterile and antiviral packaging sold globally in 2022.
• The European region holds the largest market share in the sterile and antiviral packaging market, with an estimated 27% market share in 2022.
• Industry factors such as plastic waste generation and rising healthcare costs may hinder market growth.
• Advancements in the market include the use of Blow-Fill-Seal (BFS) technology and expansions of healthcare packaging capabilities.
• FMI’s analysis shows a surge of 60 BPS in the market in H1-2022 compared to H1-2021, with a rise of 40 BPS in the projected H1-2022 outlook period.
• Sterile and antiviral packaging preserves and protects products from contamination, harmful bacteria, and air reactions, improving shelf life and providing better protection against pathogenic infections.

 “Key manufacturers of self-fusing silicone tapes are focusing on product innovation and technological integration which can allow scale of production resulting in quality product for a lower cost. This is likely to attract customers as it balances the cost and value. Organizations are also partnering and collaborating with other players in the market to tap potential markets by penetrating deeper into the filament tapes market. This enhances brand value and increase market share in the self-fusing silicone tapes market.” says an FMI analyst.

Competitive Landscape

The key market players across sterile and antiviral packaging market are coming up with launch of innovative packaging solutions made up of sustainable materials and focusing on expanding their global footprint:-

In November 2021, Becton, Dickinson and Company opened a new manufacturing facility in Zaragoza, Spain for supporting growth of pre-filled syringes in the region.

In October 2021, Becton, Dickinson and Company collaborated with U.S. Government to Covid-19 combination diagnostic tests and received initial funding of US$ 24.7 Million for the same.

Key Players:

• Becton, Dickinson and Company
• E.IE. I. Dupont De Nemours and Company
• Amcor Plc
• BillerudKorsnas AB
• Placon Corporation Inc
• Wipak Group
• ProAmpac LLC
• SteriPack Contract Manufacturing

Buy Now/Purchase: https://www.futuremarketinsights.com/checkout/11298

Global Sterile and Antiviral Packaging Market by Category

By Packaging Type :

• Thermoform Trays
• Sterile Bottles/Containers
• Vials & ampoules
• Sterile closures
• Pre-filled syringes
• Blister & clamshells
• IV Bags & pouches
• Sterile Wraps
• Others (Sterile Lids, etc.)

By Material :

• Plastics
• Glass
• Metal
• Paper & paperboard

By End Use :

• Pharmaceutical & Biological
• Surgical & Medical Instruments
• Food & Beverage Packaging
• Others

By Region :

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani  

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube